AOSIDA Trademark

Trademark Overview


On Friday, May 22, 2020, a trademark application was filed for AOSIDA with the United States Patent and Trademark Office. The USPTO has given the AOSIDA trademark a serial number of 79292114. The federal status of this trademark filing is REGISTERED as of Tuesday, July 27, 2021. This trademark is owned by HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.. The AOSIDA trademark is filed in the Pharmaceutical Products category with the following description:

Chemico-pharmaceutical preparations for the treatment of blood clots; gelatin for medical purposes, namely, donkey-hide gelatin (Ejiao) for Chinese medicinal use; raw material medicine, namely, medicinal preparations for the treatment of blood clots; biomedicine, namely, biomedicinal preparations for the treatment of blood clots; dietetic food adapted for medical purposes; dietetic substances adapted for medical purposes; nutritive substances for microorganisms for medical purposes; injectable pharmaceuticals, namely, syringes sold filled with heparin sodium, enoxaparin sodium and dalteparin sodium for the treatment of blood clots; medicated preparations for the mouth to be applied in the form of tablets; drugs for medical purposes, namely, to treat blood clots
aosida

General Information


Serial Number79292114
Word MarkAOSIDA
Filing DateFriday, May 22, 2020
Status700 - REGISTERED
Status DateTuesday, July 27, 2021
Registration Number6430583
Registration DateTuesday, July 27, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 11, 2021

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the wording "AOSIDA" above three Chinese characters.
Goods and ServicesChemico-pharmaceutical preparations for the treatment of blood clots; gelatin for medical purposes, namely, donkey-hide gelatin (Ejiao) for Chinese medicinal use; raw material medicine, namely, medicinal preparations for the treatment of blood clots; biomedicine, namely, biomedicinal preparations for the treatment of blood clots; dietetic food adapted for medical purposes; dietetic substances adapted for medical purposes; nutritive substances for microorganisms for medical purposes; injectable pharmaceuticals, namely, syringes sold filled with heparin sodium, enoxaparin sodium and dalteparin sodium for the treatment of blood clots; medicated preparations for the mouth to be applied in the form of tablets; drugs for medical purposes, namely, to treat blood clots
Transliteration StatementThe non-Latin characters in the mark transliterate to "AO SI DA" and this has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameHEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameHEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Saturday, January 15, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, December 14, 2021GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, December 14, 2021GENERIC MADRID TRANSACTION CREATED
Wednesday, October 27, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, July 29, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 29, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 29, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 27, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, May 11, 2021NOTIFICATION PROCESSED BY IB
Tuesday, May 11, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 21, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 21, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, April 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 3, 2021ASSIGNED TO LIE
Tuesday, January 5, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 9, 2020REFUSAL PROCESSED BY IB
Monday, October 19, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, October 19, 2020REFUSAL PROCESSED BY MPU
Friday, September 25, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 24, 2020NON-FINAL ACTION WRITTEN
Thursday, September 24, 2020NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, September 2, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 1, 2020NON-FINAL ACTION WRITTEN
Tuesday, August 25, 2020APPLICATION FILING RECEIPT MAILED
Monday, August 24, 2020ASSIGNED TO EXAMINER
Friday, August 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 20, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB